Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.

Scandinavian journal of infectious diseases - 1 Jan 1995

Stark K, Schreier E, Müller R, Wirth D, Driesel G, Bienzle U

Abstract excerpt

A cross-sectional study was carried out to identify risk factors for seropositivity for antibodies against hepatitis C virus (HCV) and to assess to the distribution and determinants of HCV genotypes among intravenous drug users (IVDUs). The study population consisted of 405 IVDUs. Serum specimens were tested for seromarkers for HCV, for human immunodeficiency virus (HIV), for hepatitis B virus (HBV) and for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Genotype

Share to Hepatitis B

Share to Hepatitis C

Share to Prevalence

Share to Risk Factors

Source

Identifiers

PMID: 8658065
DOI: 10.3109/00365549509032726

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.PMID 8658065Read ↗

Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users.Semantic proximity Read ↗

Hepatitis C infection among intravenous drug users attending therapy programs in CyprusSemantic proximity Read ↗

Distribution of hepatitis C virus genotypes among intravenous drug users in the Çukurova region of Turkey.Semantic proximity Read ↗

Hepatitis C virus infection among drug addicts in Italy.Semantic proximity Read ↗

Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.Semantic proximity Read ↗

Infection with hepatitis C virus among intravenous-drug users: prevalence, genotypes and risk-factor-associated behaviour patterns in Thailand.Semantic proximity Read ↗

[Distribution of the genotypes of hepatitis C virus in intravenous drug addicts in Argentina].Semantic proximity Read ↗

Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug usersSemantic proximity Read ↗

Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.Semantic proximity Read ↗

Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.Semantic proximity Read ↗

Molecular epidemiology of hepatitis C virus genotypes and subtypes among injecting drug users in Hungary.Semantic proximity Read ↗

Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.